Dynavax Technologies
DVAX
#4824
Rank
C$2.50 B
Marketcap
C$21.35
Share price
0.00%
Change (1 day)
6.46%
Change (1 year)

Earnings for Dynavax Technologies (DVAX)

Earnings in 2025 (TTM): -C$51.98 Million

According to Dynavax Technologies 's latest financial reports the company's current earnings are C$0.33 Billion. In 2024 the company made an earning of C$51.86 Million, an increase over its 2023 earnings that were of C$3.29 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Dynavax Technologies from 2004 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -C$51.98 Million-200.21%
2024 C$51.86 M1475.31%
2023 C$3.29 M-99.2%
2022 C$0.41 B238.78%
2021 C$0.12 B-257.89%
2020 -C$77.39 Million-58.58%
2019 -C$0.19 Billion-9.32%
2018 -C$0.21 Billion60.44%
2017 -C$0.13 Billion-15.8%
2016 -C$0.16 Billion4.22%
2015 -C$0.15 Billion16.54%
2014 -C$0.13 Billion37.09%
2013 -C$91.6 Million
2010 -C$65.56 Million214.85%
2009 -C$20.83 Million-37.33%
2008 -C$33.23 Million-66.07%
2007 -C$97.94 Million16.92%
2006 -C$83.76 Million170.36%
2005 -C$30.99 Million33.39%
2004 -C$23.23 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
C$14.03 B-30,175.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
C$12.36 B-26,587.25%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
C$2.14 B-4,693.07%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
C$13.49 B-29,009.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
C$30.88 B-66,267.97%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
C$19.43 B-41,731.26%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
C$13.63 B-29,301.40%๐Ÿ‡ฌ๐Ÿ‡ง UK
Agenus
AGEN
C$28.46 M-160.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
C$2.96 B-6,450.33%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel